Literature DB >> 6928996

Thymomas induced by simple alkylating agents in C57BL/Cbi mice: kinetics of the dose response.

J V Frei, P D Lawley.   

Abstract

Specific-pathogen-free inbred C57BL/Cbi mice (adult virgin females) were given single sublethal doses of N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea and were studied for a lifetime for the development of thymomas. A fatal lymphocytic lymphoma with a "starry sky" pattern due to the presence of macrophages was induced in the thymuses of treated mice within 250 days of treatment. Control and low-dose treatment groups had up to 70% incidence of a histiocytic lymphoma that was usually primary in mesenteric lymph nodes and nearly always occurred later than 250 days after treatment. A "one-hit" linear relationship existed between the time of appearance of induced thymic lymphomas and the log fraction of non-tumor-bearing mice. The absolute latency period of these tumors was constant and independent of dose. The effect of dose was an exponential increase of the total incidence of induced thymic lymphomas. By mathematical analysis, the best estimate of the exponent from the results was 2 or 3, indicating that the development of these induced tumors may be produced by 2 or 3 "events" in the target cell. Possible candidates for these events are premutagenic alkylation of DNA, inactivation of DNA repair, oncovirus activation, regenerative hyperplasia, development of trisomy No 15, and inhibited immunosurveillance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928996

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

Review 1.  AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.

Authors:  Megan A Hatlen; Lan Wang; Stephen D Nimer
Journal:  Front Med       Date:  2012-08-09       Impact factor: 4.592

2.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.

Authors:  Y Yuan; L Zhou; T Miyamoto; H Iwasaki; N Harakawa; C J Hetherington; S A Burel; E Lagasse; I L Weissman; K Akashi; D E Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

3.  Lack of ecotropic virus involvement in induction of lymphomas in DBA/2J mice by 7,12-dimethylbenz(a)anthracene.

Authors:  J A Mercer; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Carcinogenicity study in mice on pildralazine, a hydralazinelike antihypertensive compound.

Authors:  G Della Porta; T A Dragani
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Autoimmune haemolytic disease in mice after exposure to a methylating carcinogen.

Authors:  G Harris; P D Lawley; L J Asbery; P M Chandler; M G Jones
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

6.  Leukemia induction by methylnitrosourea (MNU) in selected mouse strains. Effects of MNU on hemopoietic stem cells, the immune system and natural killer cells.

Authors:  H J Seidel; L Kreja
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

7.  Deficient repair of O6-methylguanine in lymphocytes from rheumatoid arthritis families may be an acquired defect.

Authors:  C B Colaço; G Harris; P D Lawley; P M Lydyard; I M Roitt
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.

Authors:  K Yamashita; M Adachi; S Kato; H Nakagama; M Ochiai; K Wakabayashi; S Sato; M Nagao; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-05

9.  Different mutation frequencies and spectra among organs by N-methyl-N-nitrosourea in rpsL (strA) transgenic mice.

Authors:  Y Shioyama; Y Gondo; K Nakao; M Katsuki
Journal:  Jpn J Cancer Res       Date:  2000-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.